SCHEMBL23313079

SCHEMBL23313079

CCNc1ccc2ccc(OC[C@H]3O[C@@H](n4cc(-c5cn(C)cn5)c5c(N)ncnc54)[C@@H](F)[C@@H]3C)cc2n1

nearest known ligand 0.87

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 17/20 0.87
▸ METTL3 Q86U44 11/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25015668 0.93 PRMT5 (1.00) PRMT5METTL3
SCHEMBL23313246 0.86 PRMT5 (1.00) PRMT5METTL3
SCHEMBL23313941 0.85 PRMT5 (1.00) PRMT5METTL3
SCHEMBL23313159 0.81 PRMT5 (1.00) PRMT5METTL3
SCHEMBL23313151 0.79 METTL3 (1.00) PRMT5METTL3
SCHEMBL23313081 0.78 PRMT5 (1.00) PRMT5METTL3
SCHEMBL23313030 0.77 METTL3 (1.00) PRMT5METTL3
SCHEMBL23313078 0.77 PRMT5 (1.00) PRMT5METTL3
SCHEMBL23313158 0.77 PRMT5 (0.82) PRMT5METTL3
SCHEMBL23313944 0.76 PRMT5 (0.90) PRMT5METTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021079196-A9 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2022-07-14 — — WO disclosed
WO-2021079196-A2 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2021-04-29 — — WO disclosed
Send feedback